1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Infrared Spectroscopy for Pharmaceutical Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Infrared Spectroscopy for Pharmaceutical by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Infrared Spectroscopy for Pharmaceutical by Country/Region, 2018, 2022 & 2029
2.2 Infrared Spectroscopy for Pharmaceutical Segment by Type
2.2.1 FTIR
2.2.2 FT-NIR
2.2.3 Other
2.3 Infrared Spectroscopy for Pharmaceutical Sales by Type
2.3.1 Global Infrared Spectroscopy for Pharmaceutical Sales Market Share by Type (2018-2023)
2.3.2 Global Infrared Spectroscopy for Pharmaceutical Revenue and Market Share by Type (2018-2023)
2.3.3 Global Infrared Spectroscopy for Pharmaceutical Sale Price by Type (2018-2023)
2.4 Infrared Spectroscopy for Pharmaceutical Segment by Application
2.4.1 Chemical Pharmaceuticals pharmaceutical
2.4.2 Biopharmaceuticals
2.4.3 Other
2.5 Infrared Spectroscopy for Pharmaceutical Sales by Application
2.5.1 Global Infrared Spectroscopy for Pharmaceutical Sale Market Share by Application (2018-2023)
2.5.2 Global Infrared Spectroscopy for Pharmaceutical Revenue and Market Share by Application (2018-2023)
2.5.3 Global Infrared Spectroscopy for Pharmaceutical Sale Price by Application (2018-2023)
3 Global Infrared Spectroscopy for Pharmaceutical by Company
3.1 Global Infrared Spectroscopy for Pharmaceutical Breakdown Data by Company
3.1.1 Global Infrared Spectroscopy for Pharmaceutical Annual Sales by Company (2018-2023)
3.1.2 Global Infrared Spectroscopy for Pharmaceutical Sales Market Share by Company (2018-2023)
3.2 Global Infrared Spectroscopy for Pharmaceutical Annual Revenue by Company (2018-2023)
3.2.1 Global Infrared Spectroscopy for Pharmaceutical Revenue by Company (2018-2023)
3.2.2 Global Infrared Spectroscopy for Pharmaceutical Revenue Market Share by Company (2018-2023)
3.3 Global Infrared Spectroscopy for Pharmaceutical Sale Price by Company
3.4 Key Manufacturers Infrared Spectroscopy for Pharmaceutical Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Infrared Spectroscopy for Pharmaceutical Product Location Distribution
3.4.2 Players Infrared Spectroscopy for Pharmaceutical Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Infrared Spectroscopy for Pharmaceutical by Geographic Region
4.1 World Historic Infrared Spectroscopy for Pharmaceutical Market Size by Geographic Region (2018-2023)
4.1.1 Global Infrared Spectroscopy for Pharmaceutical Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Infrared Spectroscopy for Pharmaceutical Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Infrared Spectroscopy for Pharmaceutical Market Size by Country/Region (2018-2023)
4.2.1 Global Infrared Spectroscopy for Pharmaceutical Annual Sales by Country/Region (2018-2023)
4.2.2 Global Infrared Spectroscopy for Pharmaceutical Annual Revenue by Country/Region (2018-2023)
4.3 Americas Infrared Spectroscopy for Pharmaceutical Sales Growth
4.4 APAC Infrared Spectroscopy for Pharmaceutical Sales Growth
4.5 Europe Infrared Spectroscopy for Pharmaceutical Sales Growth
4.6 Middle East & Africa Infrared Spectroscopy for Pharmaceutical Sales Growth
5 Americas
5.1 Americas Infrared Spectroscopy for Pharmaceutical Sales by Country
5.1.1 Americas Infrared Spectroscopy for Pharmaceutical Sales by Country (2018-2023)
5.1.2 Americas Infrared Spectroscopy for Pharmaceutical Revenue by Country (2018-2023)
5.2 Americas Infrared Spectroscopy for Pharmaceutical Sales by Type
5.3 Americas Infrared Spectroscopy for Pharmaceutical Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Infrared Spectroscopy for Pharmaceutical Sales by Region
6.1.1 APAC Infrared Spectroscopy for Pharmaceutical Sales by Region (2018-2023)
6.1.2 APAC Infrared Spectroscopy for Pharmaceutical Revenue by Region (2018-2023)
6.2 APAC Infrared Spectroscopy for Pharmaceutical Sales by Type
6.3 APAC Infrared Spectroscopy for Pharmaceutical Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Infrared Spectroscopy for Pharmaceutical by Country
7.1.1 Europe Infrared Spectroscopy for Pharmaceutical Sales by Country (2018-2023)
7.1.2 Europe Infrared Spectroscopy for Pharmaceutical Revenue by Country (2018-2023)
7.2 Europe Infrared Spectroscopy for Pharmaceutical Sales by Type
7.3 Europe Infrared Spectroscopy for Pharmaceutical Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Infrared Spectroscopy for Pharmaceutical by Country
8.1.1 Middle East & Africa Infrared Spectroscopy for Pharmaceutical Sales by Country (2018-2023)
8.1.2 Middle East & Africa Infrared Spectroscopy for Pharmaceutical Revenue by Country (2018-2023)
8.2 Middle East & Africa Infrared Spectroscopy for Pharmaceutical Sales by Type
8.3 Middle East & Africa Infrared Spectroscopy for Pharmaceutical Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Infrared Spectroscopy for Pharmaceutical
10.3 Manufacturing Process Analysis of Infrared Spectroscopy for Pharmaceutical
10.4 Industry Chain Structure of Infrared Spectroscopy for Pharmaceutical
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Infrared Spectroscopy for Pharmaceutical Distributors
11.3 Infrared Spectroscopy for Pharmaceutical Customer
12 World Forecast Review for Infrared Spectroscopy for Pharmaceutical by Geographic Region
12.1 Global Infrared Spectroscopy for Pharmaceutical Market Size Forecast by Region
12.1.1 Global Infrared Spectroscopy for Pharmaceutical Forecast by Region (2024-2029)
12.1.2 Global Infrared Spectroscopy for Pharmaceutical Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Infrared Spectroscopy for Pharmaceutical Forecast by Type
12.7 Global Infrared Spectroscopy for Pharmaceutical Forecast by Application
13 Key Players Analysis
13.1 Thermo Fisher
13.1.1 Thermo Fisher Company Information
13.1.2 Thermo Fisher Infrared Spectroscopy for Pharmaceutical Product Portfolios and Specifications
13.1.3 Thermo Fisher Infrared Spectroscopy for Pharmaceutical Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Thermo Fisher Main Business Overview
13.1.5 Thermo Fisher Latest Developments
13.2 PerkinElmer
13.2.1 PerkinElmer Company Information
13.2.2 PerkinElmer Infrared Spectroscopy for Pharmaceutical Product Portfolios and Specifications
13.2.3 PerkinElmer Infrared Spectroscopy for Pharmaceutical Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 PerkinElmer Main Business Overview
13.2.5 PerkinElmer Latest Developments
13.3 Shimadzu
13.3.1 Shimadzu Company Information
13.3.2 Shimadzu Infrared Spectroscopy for Pharmaceutical Product Portfolios and Specifications
13.3.3 Shimadzu Infrared Spectroscopy for Pharmaceutical Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Shimadzu Main Business Overview
13.3.5 Shimadzu Latest Developments
13.4 Bruker
13.4.1 Bruker Company Information
13.4.2 Bruker Infrared Spectroscopy for Pharmaceutical Product Portfolios and Specifications
13.4.3 Bruker Infrared Spectroscopy for Pharmaceutical Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Bruker Main Business Overview
13.4.5 Bruker Latest Developments
13.5 Agilent Technologies
13.5.1 Agilent Technologies Company Information
13.5.2 Agilent Technologies Infrared Spectroscopy for Pharmaceutical Product Portfolios and Specifications
13.5.3 Agilent Technologies Infrared Spectroscopy for Pharmaceutical Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Agilent Technologies Main Business Overview
13.5.5 Agilent Technologies Latest Developments
13.6 ABB
13.6.1 ABB Company Information
13.6.2 ABB Infrared Spectroscopy for Pharmaceutical Product Portfolios and Specifications
13.6.3 ABB Infrared Spectroscopy for Pharmaceutical Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 ABB Main Business Overview
13.6.5 ABB Latest Developments
13.7 CI Semi
13.7.1 CI Semi Company Information
13.7.2 CI Semi Infrared Spectroscopy for Pharmaceutical Product Portfolios and Specifications
13.7.3 CI Semi Infrared Spectroscopy for Pharmaceutical Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 CI Semi Main Business Overview
13.7.5 CI Semi Latest Developments
13.8 Process Insights
13.8.1 Process Insights Company Information
13.8.2 Process Insights Infrared Spectroscopy for Pharmaceutical Product Portfolios and Specifications
13.8.3 Process Insights Infrared Spectroscopy for Pharmaceutical Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Process Insights Main Business Overview
13.8.5 Process Insights Latest Developments
13.9 HORIBA
13.9.1 HORIBA Company Information
13.9.2 HORIBA Infrared Spectroscopy for Pharmaceutical Product Portfolios and Specifications
13.9.3 HORIBA Infrared Spectroscopy for Pharmaceutical Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 HORIBA Main Business Overview
13.9.5 HORIBA Latest Developments
13.10 Semilab
13.10.1 Semilab Company Information
13.10.2 Semilab Infrared Spectroscopy for Pharmaceutical Product Portfolios and Specifications
13.10.3 Semilab Infrared Spectroscopy for Pharmaceutical Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Semilab Main Business Overview
13.10.5 Semilab Latest Developments
13.11 Avantes
13.11.1 Avantes Company Information
13.11.2 Avantes Infrared Spectroscopy for Pharmaceutical Product Portfolios and Specifications
13.11.3 Avantes Infrared Spectroscopy for Pharmaceutical Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 Avantes Main Business Overview
13.11.5 Avantes Latest Developments
13.12 Si-Ware
13.12.1 Si-Ware Company Information
13.12.2 Si-Ware Infrared Spectroscopy for Pharmaceutical Product Portfolios and Specifications
13.12.3 Si-Ware Infrared Spectroscopy for Pharmaceutical Sales, Revenue, Price and Gross Margin (2018-2023)
13.12.4 Si-Ware Main Business Overview
13.12.5 Si-Ware Latest Developments
13.13 Onto Innovation
13.13.1 Onto Innovation Company Information
13.13.2 Onto Innovation Infrared Spectroscopy for Pharmaceutical Product Portfolios and Specifications
13.13.3 Onto Innovation Infrared Spectroscopy for Pharmaceutical Sales, Revenue, Price and Gross Margin (2018-2023)
13.13.4 Onto Innovation Main Business Overview
13.13.5 Onto Innovation Latest Developments
13.14 Guangdong Xiaofen Instrument
13.14.1 Guangdong Xiaofen Instrument Company Information
13.14.2 Guangdong Xiaofen Instrument Infrared Spectroscopy for Pharmaceutical Product Portfolios and Specifications
13.14.3 Guangdong Xiaofen Instrument Infrared Spectroscopy for Pharmaceutical Sales, Revenue, Price and Gross Margin (2018-2023)
13.14.4 Guangdong Xiaofen Instrument Main Business Overview
13.14.5 Guangdong Xiaofen Instrument Latest Developments
13.15 Tianjin Gangdong
13.15.1 Tianjin Gangdong Company Information
13.15.2 Tianjin Gangdong Infrared Spectroscopy for Pharmaceutical Product Portfolios and Specifications
13.15.3 Tianjin Gangdong Infrared Spectroscopy for Pharmaceutical Sales, Revenue, Price and Gross Margin (2018-2023)
13.15.4 Tianjin Gangdong Main Business Overview
13.15.5 Tianjin Gangdong Latest Developments
14 Research Findings and Conclusion
※参考情報 医薬品用赤外分光分析は、医薬品の品質評価や成分分析に広く用いられる手法です。赤外分光分析は、物質が赤外線を吸収する特性を利用して、物質の構造や成分を特定する技術です。この手法は、高感度でかつ迅速な分析が可能であるため、製薬業界をはじめ、様々な分野で利用されています。 赤外分光分析の基本的な原理は、分子の振動モードに関連しています。物質に赤外線が当たると、その分子が特定の波長の赤外線を吸収し、分子内の結合が振動します。この吸収スペクトルは、物質に固有のものであり、分子の構造や官能基に基づいて異なるため、スペクトルを解析することで物質の特定が可能となります。 赤外分光分析には、主にフォトンを使用するモダリティがあり、一般的には以下の二つに分類されます。一般的な赤外分光法(FT-IR)と、近赤外分光法(NIR)です。FT-IRはフーリエ変換赤外分光法とも呼ばれ、この方法では赤外線のフーリエ変換を使用して高い解析能力を持つスペクトルを得ることができます。一方、近赤外分光法は近赤外区域の光を用いており、有機分子の特性を調べるのに適していますが、通常は分子の官能基を特定するのが難しいという特性があります。 赤外分光分析の特徴として、高速で非破壊的な分析が可能である点が挙げられます。サンプルを直接分析できるため、事前の処理が不要な場合が多く、迅速に結果を得ることができます。また、固体、液体、気体など、様々な相の物質を分析することができるため、医薬品の開発や品質管理において非常に重要です。 この技術の用途は実に多岐にわたります。製薬業界では、原料の確認や、合成中間体、最終製品の分析に利用されます。特に、特許取得や製造承認を得る際には、赤外分光率が重要な役割を果たします。また、品質管理の観点からは、製品の成分を厳密に確認し、製品の均一性や安定性を評価するために使用されます。さらに、バイオ医薬品やナノ医薬品など、近年の進展に伴い、これらの分野でも赤外分光分析の重要性が増しています。 関連技術としては、質量分析(MS)や核磁気共鳴(NMR)などが挙げられます。これらの技術は、赤外分光分析と組み合わせて用いることで、より詳細な情報を得ることができます。例えば、赤外分光分析は分子の機能基に関する情報を提供しますが、その構造に関する情報は質量分析やNMRで得ることができます。これによって、より包括的な物質の解析が行えるようになります。 さらに、最近の技術革新により、赤外分光分析も進化しています。ハイパースペクトルイメージング技術の導入により、サンプルの局所的な違いや変化を観察することが容易になっています。この技術は、医薬品の均一性検査のみならず、製品の劣化や変質の兆候を捉えるのにも役立ちます。 近年では、モバイルテクノロジーの発展により、ポータブルな赤外分光装置が登場し、現場での迅速な分析が可能になっています。これにより、製品の品質確認が製造現場でリアルタイムに行えるようになり、効率的な製造プロセスが実現されています。 医薬品における赤外分光分析は、研究開発のみならず、商業的な製造プロセスにおいても重要な役割を果たしています。国際的な医薬品規制機関が求める品質基準を満たすために、正確な分子構造の確認や成分の定量分析が不可欠です。このため、赤外分光分析技術の導入が進むと共に、その精度や信頼性を高めるための研究が続けられています。 医薬品の品質確保や新たな製品開発において、赤外分光分析の果たす役割はますます大きくなっています。環境に優しい手法であり、迅速かつ高精度な分析が求められる現代の製薬業界において、赤外分光分析は今後も重要な技術として位置づけられることでしょう。技術が進化する中で、さらなる応用が期待される分野でもあり、医薬品や関連業界全般での研究開発が進むことが望まれます。 |
*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/